$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R
HYDERABAD, India & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R
3 Generic Drug Stocks to Watch Amid Pandemic & Pricing Pressure
12:10pm, Tuesday, 17'th Aug 2021
The impact of the coronavirus pandemic on the Zacks Medical-Generic Drugs industry is expected to recede in the second half of 2021. Moreover, stable pricing and improving demand in some countries in
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q1 2021 Results - Earnings Call Transcript
05:54pm, Tuesday, 27'th Jul 2021
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q1 2021 Results - Earnings Call Transcript
2 Top Global Value Stocks to Buy Now
06:48am, Thursday, 08'th Jul 2021
Don't want to pay too steep a price for high-quality stocks? Look abroad.
Dr. Reddy's Laboratories Announces Filing of Annual Report on Form 20-F
11:58pm, Wednesday, 30'th Jun 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy's”) toda
Dr. Reddy's Laboratories Announces the Launch of Icosapent Ethyl Capsules, 1 Gram in the U.S. Market
02:07am, Tuesday, 22'nd Jun 2021
HYDERABAD, India and Princeton, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.
Global Response Aid Reports Midyear Sales Results for COVID Drug
10:00am, Thursday, 03'rd Jun 2021
DUBAI, UAE, June 3, 2021 /PRNewswire/ -- Healthcare solutions provider Global Response Aid (GRA) today reported seven-month global sales figures for its anti-viral tablet Avigan®/Reeqonus™, a drug
Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase
01:32pm, Monday, 17'th May 2021
Dr. Reddy's (RDY) earnings decline while sales grow year over year in fourth-quarter fiscal 2021.
Dr.Reddy's Laboratories Ltd (RDY) CEO Erez Israeli on Q4 2021 Results - Earnings Call Transcript
02:39pm, Friday, 14'th May 2021
Dr.Reddy's Laboratories Ltd (RDY) CEO Erez Israeli on Q4 2021 Results - Earnings Call Transcript
Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market
12:56am, Wednesday, 12'th May 2021
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R
3 Global Value Stocks to Buy Now
06:35am, Friday, 07'th May 2021
Tired of expensive stocks being just of reach? Look abroad for some great buying opportunities.
Dr. Reddy's Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market
10:41am, Thursday, 29'th Apr 2021
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Re
Sign In
Buy RDY